ScreenerHero

SCNIScinai Immunotherapeutics Ltd. American Depositary Shares

NAS · US · Healthcare · Biotechnology · scinai.com
3.220USDMkt Cap: 16.65M $P/E: 0.18

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody plat…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap16.65M $
Enterprise Value7.20M $
Revenue (TTM)1.21M $
Gross Profit-2.65M $
Net Income (TTM)-8.31M $
Revenue/Share0.4340 USD
Last Price3.220 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees45
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.18
P/E (Forward)—
PEG—
EV/EBITDA-1.04
EV/Revenue5.93
P/S1.25
P/B0.17
EPS (TTM)1.75
EPS (Forward)—
52W Range
2.85051% of range3.580
52W High3.580 USD
52W Low2.850 USD
Profitability
Gross Margin-202.29%
Oper. Margin-504.50%
EBITDA Margin0.00%
Profit Margin-633.64%
ROE-102.52%
ROA-71.45%
Growth
Revenue Growth-16.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.03M $
CapEx (TTM)24.00K $
FCF Margin-256.75%
FCF Yield-18.73%
Net Debt533.00K $
Net Debt/EBITDA-0.08
Balance Sheet
Debt/Equity0.28
Current Ratio1.35
Quick Ratio1.16
Book Value/Sh1.735 USD
Cash/Share0.8380 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.17M
Float2.81M
Insiders10074.84%
Institutions4.74%
Short Interest
Short Ratio0.1d
Short % Float0.90%
Short % Out.0.90%
Shares Short46.46K
Short (prev mo.)26.94K
Technical
SMA 500.2674 (+1104.1%)
SMA 2000.6268 (+413.7%)
Beta2.09
S&P 52W Chg21.00%
Avg Vol (30d)409.68K
Avg Vol (10d)306.97K
Technical Indicators
RSI (14)65.8
MACD0.0076
MACD Signal-0.0859
MACD Hist.+0.0935
BB Upper3.036 USD
BB Middle2.587 USD
BB Lower2.139 USD
BB Width34.63%
ATR (14)0.3634 USD
Vol Ratio (20d)7.21x